Catalent looks to bridge industry, academia on drug delivery

Catalent Pharma Solutions is looking to promote innovation and collaboration between drug developers and academics, launching its Applied Drug Delivery Institute at last week's American Association of Pharmaceutical Scientists meeting.

The initiative aims to bring together industry leaders, academic experts, customers and regulators on current and emerging drug delivery technologies, an initiative Catalent says will help improve outcomes for patients. Through bringing all of the stakeholders to the table, Catalent is looking to speed along novel treatments' paths to market, Senior Vice President Kurt Nielsen said in a statement.

"By harnessing the knowledge of some of the world's leading experts in drug development, delivery and formulation, the Institute will cultivate leadership and excellence in drug development through education, training and innovation," Nielsen said.

In practice, that means the Institute will host programs to spur mutually beneficial collaborations between industry and academia, helping them with seed funding, strategic counsel and educational programs as they pursue drug delivery solutions.

Furthermore, Catalent plans to offer Institute-led educational initiatives designed to inspire the next generation of scientific innovators in the drug delivery world, including training programs, an Institute scientific journal and a university partnership program.

- read Catalent's release

Special Report: 20 Major Pharma-Academic Alliances in 2012